The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer

BACKGROUND: Treatment for local and locoregional recurrence or second head-and-neck (H&N) cancers after previous radiotherapy is challenging, and re-irradiation carries a significantly increased risk for radiotherapy-related normal tissue toxicities and treatment failure due to a radioresistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Rühle, Alexander, Sprave, Tanja, Kalckreuth, Tobias, Stoian, Raluca, Haehl, Erik, Zamboglou, Constantinos, Laszig, Roland, Knopf, Andreas, Grosu, Anca-Ligia, Nicolay, Nils H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164259/
https://www.ncbi.nlm.nih.gov/pubmed/32299456
http://dx.doi.org/10.1186/s13014-020-01531-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164259/
https://www.ncbi.nlm.nih.gov/pubmed/32299456
http://dx.doi.org/10.1186/s13014-020-01531-5

Ejemplares similares